Article

Wilmer Eye affiliates with Saudi Arabian eye hospital

The Wilmer Eye Institute, Johns Hopkins University School of Medicine, has established a collaboration with the King Khaled Eye Specialist Hospital in Riyadh, Saudi Arabia.

Baltimore

-The Wilmer Eye Institute, Johns Hopkins University School of Medicine, has established a collaboration with the King Khaled Eye Specialist Hospital in Riyadh, Saudi Arabia.

A major focus of the affiliation will be the training of the future leaders in ophthalmology in both countries and beyond. Several Wilmer faculty members will work at the hospital for extended periods, treating patients, teaching, and conducting research.

With financial support from the Saudi government, joint research activities will focus on developing treatments for blinding eye diseases, such as diabetic eye disease, that afflict patients living in both countries and around the world. In addition, a new endowed professorship at Johns Hopkins University will be established to support the work of Hopkins faculty.

“Working in close collaboration with the excellent experts at the King Khaled Eye Specialist Hospital and combining the expertise of our two institutions will allow for more rapid evaluation of potential new therapies than would be possible with either hospital working alone,” said Peter J. McDonnell, MD, the William Holland Wilmer Professor of Ophthalmology and the director of the Wilmer Eye Institute.

Abdul Elah Al-Towerki, MD, executive director of the King Khaled Eye Specialist Hospital, echoed his comments.

“Both of our institutions have great strengths, and working closely together in this affiliation will allow us to accomplish more, in a shorter period of time, than we could working alone,” he said. “This affiliation is supported at the highest levels within the government of Saudi Arabia.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.